REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Samil Pharm. Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Samil Pharm. Co.,Ltd. Profile Updated: July 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The Company is a Korea-based manufacturer of pharmaceutical products in Korea. The Company s major products include gastrointestinal motility controlling agents, nutritions, antipyretics, anti-inflammatory agents, analgesics, gout agents, allergy agents and artificial tears. It also produces ophthalmic drugs, respiratory drugs, genito-urinary drugs, circulatory drugs, agents for diabetes mellitus, hormones, metabolic drugs, disinfectants, amino acids, dental preparations, antihistamines and others. The Company was founded on October 7, 1947 and its shares are listed on Korea Stock Exchaneg on May 29, 1985.

Headquarters
990-1 Bahngbeh-Dong, Suhchoh-Gu
Seoul; Seoul; Postal Code: 137-061

Contact Details: Purchase the Samil Pharm. Co.,Ltd. report to view the information.

Website: http://www.samil-pharm.com

Basic Information
Total Employees:
Purchase the Samil Pharm. Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Samil Pharm. Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Samil Pharm. Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Samil Pharm. Co.,Ltd. report to view the information.
Incorporation Date:
October 07, 1947
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
16.23%
Purchase this report to view the information.
9.76%
Purchase this report to view the information.
4.13%
Purchase this report to view the information.
3.94%
Purchase this report to view the information.
2.24%
Subsidiaries
삼일제약(주)
Company Performance
Financial values in the chart are available after Samil Pharm. Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-2.31%▼
Total operating revenue
-2.11%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-1018.98%▼
Total Assets
-1.02%▼
Total Equity
-14.39%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-13.41%▼
Return on Equity (ROE)
-9.64%▼
Debt/Equity
24.93%▲
Quick Ratio
-0.1%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo